Active Ingredient(s): Dolutegravir + Rilpivirine
FDA Approved: * November 21, 2017
Pharm Company: * VIIV HLTHCARE
Category: HIV / AIDS

Dolutegravir (DTG), sold under the brand name Tivicay, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS.[4] It may also be used, as part of post exposure prophylaxis, to prevent HIV infection following potential exposure.[5] It is taken by mouth.[4] Common side effects include trouble sleeping, feeling tired, diarrhea, high blood sugar, and headache.[5] Severe side effects may include allerg... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Juluca Oral Tablet, Film Coated
NDC: 49702-242
Viiv Healthcare Company